A critical breakthrough in cancer research is occurring with the use of VHH fragments to re-engage dysfunctional p53. This crucial malignant protector protein is frequently disabled in many kinds of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research